Search Results 1541-1550 of 18134 for Alcoholics
Tolvanen L, Mossberg K, Grace LM, Standen EC, Phelan S, Andersson DP, Koball AM. Primary Care Providers Perspectives of GLP-1 Receptor Agonists to Manage ...
Kinard TN, Williams L, Schroeder ML, Lu Q, Adamski J. Therapeutic Plasma Exchange Used in the Treatment of Clostridium perfringens Septicemia With Hemolysis ...
[MUSIC PLAYING]. Weight Loss Care Mayo Clinic Bariatric Center in Florida. Kirsten Frederiksen, M.D., Medical Director, Bariatric Center, Florida: The ...
This study is being done to look at the cardiovascular response, if any, to intake of commercially available energy drink. We hypothesize that energy drink ...
Costello CM, Ho A, Kechter J, Nussbaum RL, Esplin ED, Branoff J, Kunze KL, Golafshar MA, Samadder NJ, Mangold AR. Germline cancer susceptibility gene ...
PRM-151 is an investigational drug that is being developed for possible use in the treatment of myelofibrosis (MF), a disease in which the bone marrow, which is ...
Ali J. Ainsworth, M.D. · Patient Stories · National Doctors' Day is March 30! · About Mayo Clinic · Medical Professionals · Businesses · Students · Researchers.
Fibromyalgia is a disorder that causes pain all over the body, sleep problems, fatigue, and often emotional and mental distress.
This latent reservoir that exists in memory cells within the immune system (CD4) has been untouchable and remains the largest barrier in curing rather than ...
Assis MLM, Sabsevitz DS, Merchant KS, DeDeo M, Quinones-Hinojosa A, Chaichana KL, Crowe WT, Bojaxhi E, Woeste J, Gruenbaum SE, Logvinov II, De Ruyter ML, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.